You are using an outdated browser. Please upgrade your browser to improve your experience.

neratinib

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Neratinib is a kinase inhibitor that irreversibly binds to Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and HER4. In vitro, neratinib reduces EGFR and HER2 autophosphorylation, downstream MAPK and AKT signaling pathways, and showed antitumor activity in EGFR and/or HER2 expressing carcinoma cell lines. Neratinib human metabolites M3, M6, M7 and M11 inhibited the activity of EGFR, HER2 and HER4 in vitro. In vivo, oral administration of neratinib inhibited tumor growth in mouse xenograft models with tumor cell lines expressing HER2 and EGFR.
Synonyms & Links
Guide to Pharmacology: 5686
DrugCentral: 5252
LyCHI:  V4KPNPBCJPMY


loading...
Target Activities